USC Roski Eye Institute

02/13/2026

Congratulations to Dr. Andrew Moshfeghi, who was selected as Top Doctors for 2026 by Castle Connolly Top Doctors. Castle Connolly Top Doctors represent the top 7% of all U.S. practicing physicians. These doctors are best-in-class healthcare providers, embodying excellence in clinical care as well as interpersonal skills.

02/04/2026

01/28/2026

“Where I am now is ‘give-back’ time,” the Half Century Trojan says.

01/21/2026

At USC Roski Eye Institute, oculofacial plastic surgery is a true team effort, blending expertise across several disciplines, which include dermatologists, otolaryngologists, general plastic surgeons, and even ocular oncologists.

Every year and a half, our residents and fellows have the opportunity to participate in our critically acclaimed USC Oculofacial Plastic Surgery Surgical Skills Course, which brings top minds together to train, learn, and innovate.

01/20/2026

In our mission to preserve, protect and restore sight, the vision researchers at the USC Roski Eye Institute play a critical role in driving fundamental and translational research to advance patient care. Ranked #4 in NIH research funding, the ophthalmology departments scientists and clinicians conduct exemplary research with direct impact on improving diagnostic evaluation and treatment of major eye diseases, including age-related and hereditary macular degeneration, dry eye, diabetic retinopathy, and glaucoma. The USC Roski Eye Institute has a rich and diverse research program that focuses on five research areas: Bioengineering and Nanotechnology, Epidemiology, Imaging, Inflammation and Regeneration, and Neurodegeneration.

01/06/2026

Shout out to Dr. Andrew Moshfeghi, medical director of the USC Roski Eye Institute and associate professor of clinical ophthalmology, who presented on Practical Tips for the Management of Patients with Geographic Atrophy at the Retina World Congress.

12/31/2025

In Ophthalmology Times, Dr. Mark Humayun discusses advance stem cell-derived therapies for dry age-related macular degeneration. Read more: https://www.ophthalmologytimes.com/view/mark-humayun-md-phd-discusses-advance-stem-cell-derived-therapies-for-dry-amd

12/23/2025

In Ophthalmology Times, Dr. Gloria Chiu discusses factors affecting adoption of the FDA-approved epi-on therapy, from clinic setup to insurance coverage, while highlighting its safety and efficacy. Read more:

Chiu discusses factors affecting adoption of the FDA-approved epi-on therapy, from clinic setup to insurance coverage, while highlighting its safety and efficacy.

12/19/2025

Our researchers are exploring if a stem cell-derived patch can help replace cells damaged by age-related macular degeneration and restore vision. The cells are attached to an implant, an ultra-thin patch, which holds the cells in place. Learn more: https://news.keckmedicine.org/can-a-retinal-implant-reverse-macular-degeneration/

LOS ANGELES — Age-related macular degeneration, the leading cause of vision loss and blindness for Americans 65 and older, is a progressive disease affecting central vision. Over time, faces, book pages and anything directly in front of a person become obscured by blurry, dark or blind spots.Now, ...

12/11/2025

Cataracts can cause vision loss, and even blindness, unless a patient gets surgery. Fortunately, cataract surgery is safe, common and highly effective. Kristina Voss, MD, ophthalmological surgeon at the USC Roski Eye Institute, breaks down what causes cataracts, who’s at risk and why surgery is such a reliable solution. Learn more here: https://www.keckmedicine.org/blog/what-is-cataract-surgery/.

11/26/2025

We are thankful for you Dean Meltzer!

This Thanksgiving, I am grateful for:

‣Students asking tough questions that even seasoned faculty have to think about

‣Laughter during stressful times

‣Researchers who celebrate both breakthroughs and failed experiments, because both move science forward

‣Faculty who are excited about teaching (and learning from!) their students

‣The joy that comes from our wonderful community partnerships

‣A patient who shares how their Keck care made all the difference

‣The simple fact that the work we do matters. . . every day

Happy Thanksgiving to all.

—Dean Carolyn Meltzer, MD

11/26/2025

As we head into the Thanksgiving holiday, we extend our heartfelt gratitude to everyone who makes our department thrive. Your hard work, compassion and support uplift our entire community. Wishing you all a safe and happy Thanksgiving.